This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca on December 18, 2018 at 5:13 am
Ignyta was best known as one of the companies trying to develop “tissue agnostic” cancer drugs; that is, drugs that home in on a tumor’s genetic fingerprint, regardless of where in the body ... […]
- Young Boy Battling Cancer Gets Dream Job for a Day, Thanks to Queensland Police on December 17, 2018 at 4:33 am
Tom is fighting brain cancer, according to a press release issued by the station ... the brothers participating in many of the daily duties of a constable, including fingerprinting and conducting spee... […]
- Seer Launches to Develop Liquid Biopsy for Cancer, Brain Disease on December 17, 2018 at 4:03 am
The cancer nanomedicine researcher has cofounded ... certain diseases that may lack a clear, detectable genetic fingerprint, like some neurological disorders. Farokhzad adds that Seer, which ... […]
- Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases on December 17, 2018 at 4:00 am
Seer, Inc., launched today to capture and translate molecular insights from the proteome to enable early detection of cancer and neurological diseases ... This yields a biomolecular fingerprint of hea... […]
- How can powder containing talc lead to cancer? on December 16, 2018 at 2:15 am
Consumer groups have also found it in crayons and children’s toys, like crime-scene fingerprint kits ... claim the powder caused their ovarian cancer because they used it for feminine hygiene ... […]
- Cancer as Weapon: Poppy Bush’s Radioactive War on Iraq on December 7, 2018 at 1:18 am
Most of the leukemia and cancer victims aren’t soldiers ... let’s not forget that Bush’s fingerprints are all over the October Surprise of 1980, when emissaries from the Reagan campaign convinced the ... […]
- ‘Universal fingerprint’ in cancer DNA points to potential blood test. But it’s not ready for patients on December 5, 2018 at 10:00 am
A ‘universal cancer test’ is big news today, with headlines claiming that the test will be able to detect any cancer in just 10 minutes. While the science behind the headlines is exciting, the reality ... […]
- Patient data base could help doctors be proactive withe cancer patients on December 4, 2018 at 7:29 pm
"total cancer care" seeks to provide more information, options and enhanced care for patients. He said about 600 patients are added weekly. Dalton said all patients are different, like fingerprints di... […]
- Qld researchers develop ten minute cancer test on December 4, 2018 at 5:35 pm
The research found a “universal fingerprint” in the DNA of common cancers that ... Researchers demonstrated that there is a tell-tale pattern of gene expression in cancer genomes which is not found in ... […]
via Bing News